News


Resident News

ProteoFormiX Awarded € 265K VLAIO Research Grant

By JLABS

Read full story
Resident News

S-Biomedic is Gearing up for Significant Growth

By JLABS

Read full story
Resident News

Glyscend Therapeutics Completes $20.5M Financing Round to Advance Novel Oral Polymer Therapy for Type 2 Diabetes

By JLABS

Read full story
Resident News

SpaceX Demo-2 Astronauts Get to Work on Space Station Science - Cam Med, Inc Project

By JLABS

Read full story
Resident News

Immunoscape studying immune response to Covid-19

By JLABS

Read full story
Resident News

AlphaBiomics wins award to validate its IBD biologic therapy response predictor RxSelex

By JLABS

Read full story
Resident News

Alumni Dragonfly Therapeutics Announces Multi-Target Expansion of its Collaboration with Merck to Use Dragonfly's Proprietary TriNKET™ Platform to Develop Novel Therapeutic Candidates in the fields of Oncology, Infectious Disease, and Immune Disorders

By JLABS

Read full story
Resident News

JLABS Alumni Kymera Therapeutics Announces $102 Million Series C Financing to Advance its Protein Degrader Pipeline and Platform

By JLABS

Read full story
Other news

Knowledge for Growth 2018 Recap

By Janssen Belgium

Read full story
Other news

Want to know more about the JLABS Portfolio?

By JLABS

Read full story
In the media

J&J extends its JLABS incubator scheme to Europe

By Phil Taylor

Read full story
In the media

Belgium chosen for first J&J ‘JLABS’ incubator in Europe

By Andrew McConaghie

Read full story
Other news

Next stop, Europe! @JNJInnovation introduces @JLABS in Belgium

By JLABS

Read full story
In the media

Johnson & Johnson opens first European JLABS incubator

By Nick Paul Taylor

Read full story